European shares drop as policymakers seek to tame hot inflation
European shares dropped on Monday, while bond yields surged as comments from central bank policymakers heightened fears of aggressive measures to stamp out inflation amid rising risks of a recession.
Philip Morris, Carlyle could fight it out for UK’s Vectura in auction ring
The takeover battle for drugmaker Vectura (VEC.L) will enter a rare head-to-head auction process if private equity group Carlyle (CG.O) and tobacco giant Philip Morris (PM.N) do not make final bids by Tuesday, according to a British regulator.
AstraZeneca COVID-19 sales jump as drugmaker navigates vaccine challenges
Second-quarter sales of AstraZeneca’s (AZN.L) COVID-19 vaccine more than tripled to $894 million from the first quarter, but the drugmaker on Thursday again delayed its U.S. application for approval as it gathers more data for submissions.
New York, drug distributors reach $1.18 bln opioid settlement as national deal looms
The three largest U.S. drug distributors agreed mid-trial to pay up to $1.18 billion to settle claims by New York state and two of its biggest counties over their role in the nationwide opioid epidemic, the state’s attorney general said on Tuesday.
U.S. pharmacies strike first deals with counties over opioids
Pharmacy operators Walgreens Boots Alliance Inc(WBA.O), CVS Health Corp(CVS.N), Rite Aid Corp(RAD.N) and Walmart Inc(WMT.N) have agreed to pay a combined $26 million to settle claims by two New York counties that they fueled an opioid addiction epidemic.
Nasdaq ends at record high as Big Tech companies roar back
The Nasdaq ended at a record high on Tuesday, lifted by Amazon, Microsoft and other top-shelf tech companies as investors shifted their focus to growth stocks.
What you need to know about the coronavirus right now
Here’s what you need to know about the coronavirus right now.
Danish ‘meme stock’ Orphazyme plunges after drug setback
Orphazyme (ORPHA.CO) slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate, sending shares in Denmark’s first so-called meme stock tumbling 75% in early trading.
U.S. to donate 500 million Pfizer doses to poor nations
The United States will spend $3.5 billion to buy and donate 500 million doses of the Pfizer (PFE.N) coronavirus vaccine to some of the world’s poorest countries, it said on Thursday, urging other G7 nations to follow suit.
Asia shares pare gains on caution, oil falls again
Asia stocks reversed early gains on Tuesday, with traders sidelined ahead of U.S. inflation data and a European monetary policy meeting this week while oil prices lost more ground on worries over the fragile state of the global recovery.
